← Leaderboards
Lyndsey Linke
Sivec Biotechnologies, Llc
$3,627,875
Attributed
$3,627,875
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2018–22$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,627,875 · 3
By mechanism
R44$3,048,652 · 1
R43$579,223 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Small Hairpin Rna”
- Tony Yuen · Icahn School Of Medicine At Mount Sinai$6,251,237
- Patrizia Caposio · Oregon Health & Science University$4,849,550
- Lindsey Ingerman James · Univ Of North Carolina Chapel Hill$4,429,846
- Andrew Josef Ewald · Johns Hopkins University$4,378,236
- Robert Charles Moen · Inomagen Therapeutics, Inc$3,849,106
- Hu Huang · Johns Hopkins University$3,797,670
Research focus
Small Hairpin RnaViral VectorMouse ModelSafetyIn VivoTissuesCellsGenomicsMucous MembraneNucleic AcidsClinically RelevantImmunogenicityIn VitroTechnologyBacteriaBaseEngineeringEpithelialGenesBiodistributionNoseBiotechnologyClinical ApplicationInvaded
Grant awards (5)
Preclinical development of a biological antiviral for universal influenza treatment and prophylaxis using a novel nucleic acid delivery platform$1,000,088
R44 · FY2022 · AI · contact PI
Preclinical development of a biological antiviral for universal influenza treatment and prophylaxis using a novel nucleic acid delivery platform$1,019,722
R44 · FY2021 · AI · contact PI
A large-capacity bacterial platform for the production and targeted delivery of gene editing systems$286,081
R43 · FY2021 · TR · contact PI
Preclinical development of a biological antiviral for universal influenza treatment and prophylaxis using a novel nucleic acid delivery platform$1,028,842
R44 · FY2020 · AI · contact PI
A versatile transkingdom platform for therapeutic nucleic acid delivery to mucosal epithelial tissues$293,142
R43 · FY2018 · AI · contact PI